Clinical trials are the foundation of modern medicine. They determine whether a new drug, therapy, or medical device or procedure is safe, effective, and ready for widespread use.

But behind the science lies a growing operational challenge: keeping patients engaged, monitored, and compliant throughout the study.

As trials become more complex and regulators demand stronger documentation and patient oversight, traditional clinical trial workflows are struggling to keep up.

The result?Higher costs, overburdened research staff, and an increased risk of protocol deviations, patient dropout, and compromised study outcomes.

Emerging technologies, particularly conversational AI and remote monitoring platforms like Calico Care, are helping research teams address these challenges while improving both data quality and patient experience.

The Regulatory Shift Toward Remote Monitoring and Better Documentation

The U.S. Food and Drug Administration has recently emphasized the importance of decentralized and hybrid clinical trial models that allow participants to engage with studies from their homes. 

These decentralized approaches may include:

• Telehealth visits with study personnel

• Remote symptom monitoring

• Digital health technologies collecting patient-reported data

• At-home participation in study activities 

The FDA’s guidance encourages these tools because they can:

• Reduce participant burden

• Expand access to more diverse populations

• Improve the efficiency of clinical trials 

However, the shift toward remote participation does not reduce regulatory expectations.

The FDA makes it clear that decentralized trials must still maintain the same standards for:

• patient safety

• documentation

• data integrity

• monitoring and oversight 

For research teams, this creates a difficult balancing act: more data to collect, more patients to engage, and more documentation to maintain, without a proportional increase in staff.

The Hidden Risk: Patient Dropout and Protocol Deviations

One of the biggest operational challenges in clinical studies is patient retention and protocol compliance.

Patients may unintentionally deviate from the study protocol by:

• forgetting to report symptoms

• skipping medication schedules

• failing to complete required surveys

• missing scheduled follow-ups

When this happens, it can lead to:

• protocol non-compliance

• missing or incomplete datasets

• patient disqualification

• delayed regulatory submissions

These risks increase when research teams are responsible for manually monitoring hundreds of participants across long study timelines.

At the same time, research coordinators and nurses are already facing staffing shortages and increasing workloads across healthcare systems.

The reality is simple: human teams alone cannot maintain continuous engagement with every study participant.

A New Layer of Support for Research Teams

This is where conversational monitoring platforms like Calico Care can make a meaningful difference.

Instead of relying solely on periodic check-ins, Calico Care allows research teams to deploy automated conversational workflows that continuously engage study participants between visits.

Cali, the platform’s conversational AI assistant, can:

• Conduct structured check-ins with participants

• Collect patient-reported outcomes

• Identify potential protocol deviations

• Flag concerning symptoms for review

• Document responses in structured reports for research teams

This approach helps transform clinical monitoring from episodic interactions into continuous engagement.

The benefits can include:

• improved patient adherence

• earlier detection of study issues

• reduced manual documentation workload

• stronger datasets for regulatory review

Most importantly, it helps ensure that participants feel supported and connected throughout the study, which is a key factor in improving retention.

Designing Workflows Around Each Study

Every clinical trial is different.

Study designs vary in:

• patient populations

• monitoring requirements

• protocol complexity

• duration and endpoints

Calico Care is designed to work alongside research teams, not replace them.

Conversational workflows can be tailored to:

• the study protocol

• symptom monitoring requirements

• medication adherence checks

• patient education and reminders

This flexibility allows the platform to support a wide range of clinical study types

The Opportunity Ahead

Clinical research is entering a new era.

Regulators are encouraging digital tools, decentralized participation, and better patient monitoring. At the same time, research organizations must maintain strict standards for data integrity, documentation, and oversight.

Technology alone is not the solution but when implemented thoughtfully, it can give clinical teams the support they need to scale research safely and efficiently.

Conversational AI platforms like Calico Care represent one step toward a future where:

• patients remain engaged throughout the study

• research teams gain better visibility into participant health

• studies produce stronger, more complete datasets

And ultimately, where new therapies can reach patients faster.

Explore How Calico Care Can Support Clinical Research

If you are designing a clinical study or exploring decentralized trial models, Calico Care can help research teams improve patient engagement and monitoring while reducing manual workload.

Learn how Calico Care can support your next clinical study.

Explore our platform or request a demo at www.calico.care

Sources

• U.S. Food and Drug Administration Conducting Clinical Trials with Decentralized Elements Guidance

• Applied Clinical Trials FDA Decentralized Clinical Trial Guidance

• Association of Clinical Research Professionals Patient Retention in Clinical Trials

• Clinical Trial Vanguard How FDA Guidance on Decentralized Trials Applies to Research Execution